MedTrace Logo

Evaluation of an Intensive Individualized Smoking Cessation Program Delivered by Pharmacists

NCT03597607 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 150

Last updated 2022-04-27

No results posted yet for this study

Summary

This study aims to look at the efficacy and impact of a pharmacist-led smoking cessation program. It will assess an intensive program and an abbreviated program, with the latter being evaluated for feasibility in community pharmacies. Participants will be in one of two groups: intensive or abbreviated. Smoking abstinence rates, self-efficacy and overall satisfaction will be compared. Additionally, a cost-effectiveness analysis will be executed to determine the feasibility of customized smoking cessation programs in community pharmacies across Newfoundland and Labrador.

Conditions

  • Smoking Cessation
  • Smoking, Tobacco
  • Quality of Life

Interventions

BEHAVIORAL

Intensive Smoking Cessation Group

This group will meet with the pharmacist more frequently and for longer periods than other groups.

BEHAVIORAL

Abbreviated Smoking Cessation Group

This group will meet with the pharmacist less frequently and for shorter periods in comparison to the intensive group.

Sponsors & Collaborators

  • Memorial University of Newfoundland

    lead OTHER

Principal Investigators

  • Terri Genge · Memorial University, School of Pharmacy

  • Leslie Phillips · Memorial University, School of Pharmacy

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
19 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-09-18
Primary Completion
2020-09-25
Completion
2022-04-05

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03597607 on ClinicalTrials.gov